Thromb Haemost 1966; 15(03/04): 428-435
DOI: 10.1055/s-0038-1649444
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Clot-Promoting Effect of Adenosine-5’- Diphosphate (ADP). I. Mechanisms of Action

J Pizzuto*
1   Department of Medicine and Laboratory for the Study of Hereditary and Metabolic Disorders University of Utah College of Medicine, Salt Lake City, Utah, U.S.A
,
A.J Giorgio
1   Department of Medicine and Laboratory for the Study of Hereditary and Metabolic Disorders University of Utah College of Medicine, Salt Lake City, Utah, U.S.A
,
P Didisheim**
1   Department of Medicine and Laboratory for the Study of Hereditary and Metabolic Disorders University of Utah College of Medicine, Salt Lake City, Utah, U.S.A
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Summary

1. ADP accelerates blood coagulation by at least two mechanisms. One is by causing release of coagulant phospholipids from platelets. The other is by activation of a plasma coagulation factor whose action is early in thromboplastin generation.

2. Possible mechanisms of ADP’s effect on blood coagulation are discussed.

3. These findings suggest that ADP may play a more significant role in the mechanisms of hemostasis and in the pathophysiology of thrombosis than has heretofore been supposed.

* Present address: Hospital de Enfermedades de la Nutricion, Mexico City, Mexico.


** Present address: Mayo Clinic, Rochester, Minn., U.S.A.


 
  • References

  • 1 Arakawa T, Spaet TH. Hypercoagulability and thrombosis: Effect of injected thrombo- kinase and adenosine diphosphate on established microthrombi in rabbits. Proc. Soc. exp. Biol. (N. Y) 16: 1034 1964;
  • 2 Born GVR, Gross MJ. The effect of inorganic ions on the aggregation of platelets by ADP. J. Physiol. (Lond) 168: 41P 1963;
  • 3 Born GVR, Cross MJ. The aggregation of blood platelets. J. Physiol. (Lond) 168: 178 1963;
  • 4 Born GVR, Honour AJ, Mitchell JRA. Inhibition by adenosine and by 2-chloro- adenosine of the formation and embolization of platelet thrombi. Nature 202: 761 1964;
  • 5 Caen J, Michel H. L’activité agrégante du serum. (Plasma défibriné par la thrombine). Rev. franç. Étud. clin. biol 09: 1001 1964;
  • 6 Ghen RF, Brown DM, Plant GWE. DPN-linked isocitrate dehydrogenase of bovine heart: Structural changes associated with activation by ADP. Biochemistry 03: 552 1964;
  • 7 Ghiga M, Plaut GWE. An enzyme system from mitochondria catalyzing ADP, ATP, and orthophosphate ATP exchange reactions. J. biol. Chem 234: 3059 1959;
  • 8 Gohn WE. The anion exchange separation of ribonucleotides. J. Amer. chem. Soc 72: 1471 1950;
  • 9 Davie EWO, Ratnoff D. Waterfall sequence for intrinsic blood clotting. Science 145: 1310 1964;
  • 10 DesPrez RM. Effects of bacterial endotoxin on rabbit platelets. III. Comparison of platelet injury induced by thrombin and by endotoxin. J. exp. Med 120: 305 1964;
  • 11 Didisheim P, Mibashan RS. Activation of Hageman factor (Factor XII) by long-chain saturated fatty acids. Thrombos. Diathes. haemorrh. (Stuttg) 09: 346 1963;
  • 12 Didisheim P, Pizzuto J, Bunting D. An improved assay for Factor IX (PTC, Christmas factor). In: Brinkhous KM. (ed). The Hemophilias. Univ. North. Carolina Press; Chapel Hill: 1964
  • 13 Gaarder A, Jonsen J, Laland S, Hellem AJ, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192: 531 1961;
  • 14 Hellem AJ, Owren PA. The mechanism of the hemostatic function of blood platelets. Actahaemat. (Basel) 31: 230 1964;
  • 15 Hovig T, Holmsen H. Release of a platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg) 09: 264 1963;
  • 16 Kuby AS, Mahowald TA, Noltman EA. Studies on adenosine triphosphate transphos- phorylases. IV. Enzyme substrate interactions. Biochemistry 01: 748 1962;
  • 17 Lewis JH, Didisheim P. Differential diagnosis and treatment in hemorrhagic disease. A.M.A. Arch, intern. Med 100: 157 1957;
  • 18 Macfarlane RG. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 202: 498 1964;
  • 19 Martell AE, Calvin M. Chemistry of the metal chelate compounds. Prentice Hall; New York: 1952
  • 20 McLean JR, Maxwell RE, Hertler D. Fibrinogen and adenosine diphosphate-induced aggregation of platelets. Nature 202: 605 1964;
  • 21 Mustard JF, Hegardt B, Rowsell HC, MacMillan RL. Effect of adenosine nucleotides on platelet aggregation and clotting time. J. Lab. clin. Med 64: 548 1964;
  • 22 Nordoy A, Chandler AB. The influence of dietary fats on the adenosine diphosphate induced platelet thrombosis in the rat. Scand. J. Haemat 01: 202 1964;
  • 23 Nossel HL. “The Contact Phase of Blood Coagulation.”. F.A. Davis Company, Philadelphia. Blackwell Scientific Publications; 1964
  • 24 Nye SW, Graham JB, Brinkhous KM. The partial thromboplastin time as a screening test for the detection of latent bleeders. Amer. J. med. Sei 243: 279 1962;
  • 25 O’Brien JR. The effect of some fatty acids and phospholipids on blood coagulation. Brit. J. exp. Path 38: 529 1957;
  • 26 O’Brien JR. Platelet aggregation: Part I. Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. Part II. Some results from a new method of study. J. Clin. Path 15: 446 1962;
  • 27 O’Brien JR. A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. clin. Path 17: 275 1964;
  • 28 Ödegaard AE, Skâlhegg BA, Hellem AJ. ADP induced platelet adhesiveness as a diagnostic test in von Willebrand’s disease. Thrombos. Diathes. haemorrh. (Stuttg) 09: 23 1964;
  • 29 Ödegaard AE, Skâlhegg BA, Hellem AJ. Increased activity of “anti-von Willebrand Factor” in diabetic plasma. Thrombos. Diathes. haemorrh. (Stuttg) 09: 27 1964;
  • 30 Ödegaard AE, Skâlhegg BA, Hellem AJ. Investigation of adenosine diphosphate (ADP) induced platelet adhesiveness in vitro. Part III. The inactivation of ADP in plasma. Thrombos. Diathes. haemorrh. (Stuttg) 09: 317 1964;
  • 31 Owren PA. Physiopathologie du temps de saignement. Nouv. Rev. franc. Hémat 03: 280 1963;
  • 32 Owren PA. Nutrition and thrombosing atherosclerosis. Nutr. et Dieta (Basel) 06: 156 1964;
  • 33 Owren PA, Hellem AJ, Odegaard A. Linolenic acid for the prevention of thrombosis and myocardial infarction. Lancet Nov 07: 975 1964;
  • 34 Rodman Jr. NF, Mason RO, Brinkhous KM. Some pathogenetic mechanisms of white thrombus formation: agglutination and self-destruction of the platelet. Fed. Proc 22: 1356 1963;
  • 35 Rowsell HC, Murphy EA, Glynn MF, Mustard JF. Adenosine nucleotides, platelets and thrombosis in swine. Blood 25: 603 1965; (Abstract).
  • 36 Salzman EW, Chambers DA. Inhibition of ADP-induced platelet aggregation by substituted amino acids. Nature 204: 698 1964;
  • 37 Salzman EW, Chambers DA, Neri LL. Platelet aggregation and incorporation of labelled nucleotides. Fed. Proc 24 No. 2, Part I, 260 1965; (Abstract).
  • 38 Skâlhegg A, Hellem AJ, Odegaard AE. Investigations on adenosine diphosphate (ADP) induced platelet adhesiveness in vitro. Part II. Studies on the mechanism. Thrombos. Diathes. haemorrh. (Stuttg) 09: 305 1964;
  • 39 Weaver R. Nucleoside diphosphokinases. In: The Enzymes. Vol. 6 Boyer, Lardy, Myrback. editors. Academic Press; New York: 1962
  • 40 Zucker-Franklin D, Spaet TH. Partial purification of intermediate coagulation Product I and a study of its properties. Amer. J. Physiol 205: 341 1963;